JDRF, New York, New York 10004, USA.
Diabetes Technol Ther. 2013 Jun;15 Suppl 2:S2-4-S2-7. doi: 10.1089/dia.2013.0106.
George Eisenbarth's pioneering and visionary research has provided a critical foundation that will be built on in the years ahead as we progress toward prevention of type 1 diabetes. His almost 30-year old model that type 1 diabetes was a chronic and predictable autoimmune disease with multiple identifiable progressive stages with a potential for interventions to prevent progression to symptomatic diabetes has stood the test of time. To deliver on the Eisenbarth vision and his "unfinished journey," the field needs: (1) to improve detection of risk of type 1 diabetes, (2) to improve staging and prediction of progression, (3) to perform smaller, shorter, practical, and an increased number of prevention clinical trials, and (4) to increase awareness of the potential for risk detection, staging, and prevention of type 1 diabetes and benefit/risk of prevention.
乔治·艾森巴思的开创性和富有远见的研究为我们在未来几年预防 1 型糖尿病的工作中提供了一个重要的基础。他近 30 年前提出的模型认为,1 型糖尿病是一种慢性、可预测的自身免疫性疾病,具有多个可识别的渐进阶段,有可能通过干预来阻止疾病进展到有症状的糖尿病。为了实现艾森巴思的愿景和他的“未竟之旅”,该领域需要:(1)提高 1 型糖尿病风险的检测能力,(2)改善疾病进展的分期和预测,(3)开展更小、更短、更实用、更多数量的预防临床试验,(4)提高对 1 型糖尿病风险检测、分期和预防的可能性以及预防的获益/风险的认识。